NPV - Mexico regulatory authority lists Sorrento's COVID-19 test as approved for emergency use

Sorrento Therapeutics (SRNE) announces that the health regulatory authority for Mexico has listed COVI-STIX on its official government website list of rapid antigen tests approved for emergency use in the country.COVI-STIX is a rapid (~15-minute) diagnostic test for the detection of the SARS-CoV-2 virus nucleocapsid antigen in nasal or nasopharyngeal samples of patients.Among all the products listed currently, COVI-STIX outperformed for both Sensitivity (91.89%) and Specificity (99.23%),the company said.Shares up nearly 8% premarket.

For further details see:

Mexico regulatory authority lists Sorrento's COVID-19 test as approved for emergency use